Abstract High levels of homocysteine (Hcy) known as hyperhomocysteinemia (HHcy), contribute to autophagy and ischemia/reperfusion injury (I/R). Previous studies have shown that I/R injury and HHcy cause increased cerebrovascular permeability; however, the associated mechanism remains obscure. Interestingly, during HHcy, cytochome-c becomes homocysteinylated (Hcy-cyto-c). Cytochrome-c (cyto-c) transports electrons and facilitates bioenergetics in the system. However, its role in autophagy during ischemia/reperfusion injury is unclear. Tetrahydrocurcumin (THC) is a major herbal antioxidant and anti-inflammatory agent. Therefore, the objective of this study was to determine whether THC ameliorates autophagy during ischemia/reperfusion injury by reducing homocysteinylation of cyto-c in hyperhomocysteinemia pathological condition. To test this hypothesis, we employed 8-10-week-old male cystathionine-beta-synthase heterozygote knockout (CBS+/−) mice (genetically hyperhomocystemic mice). Experimental group was: CBS+/−, CBS+/−+ THC (25 mg/kg in 0.1% DMSO dose); CBS (+/−)/I/R, and CBS (+/−)/I/R+THC (25 mg/kg in 0.1% DMSO dose). Ischemia was performed for 30 min and reperfusion for 72 h. THC was injected intra-peritoneally (I.P.) once daily for a period of 3 days after 30 min of ischemia. The infarct area was measured using 2,3,5-triphenyltetrazolium chloride staining. Permeability was determined by brain edema and Evans Blue extravasation. The brain tissues were analyzed for oxidative stress, matrix metalloproteinase-9 (MMP-9), damageregulated autophagy modulator (DRAM), and microtubuleassociated protein 1 light chain 3 (LC3) by Western blot. The mRNA levels of S-adenosyl-L-homocysteine hydrolases (SAHH) and methylenetetrahydrofolate reductase (MTHFR) genes were measured by quantitative real-time polymerase chain reaction. Co-immunoprecipitation was used to determine the homocysteinylation of cyto-c. We found that brain edema and Evans Blue leakage were reduced in I/R+THC-treated groups as compared to sham-operated groups along with reduced brain infarct size. THC also decreased oxidative damage and ameliorated the homocysteinylation of cyto-c inpart by MMP-9 activation which leads to autophagy in I/R groups as compared to sham-operated groups. This study suggests a potential therapeutic role of dietary THC in cerebral ischemia.
Introduction
Cerebral stroke is a major cause of morbidity and mortality worldwide. Many studies indicate a plethora of risk factors for cerebral stroke (i.e., hypertension, obesity, smoking, and diabetes mellitus) (Manolescu et al. 2010) . Nevertheless, cerebrovascular events can occur sometimes in individuals without any of the previously mentioned risk factors. Homocysteine is a thiol-containing amino acid formed during the methionine metabolism via methylation to homocysteine which requires S-adenosyl-L-homocysteine hydrolases (SAHH), remethylation to methionine, which requires methylenetetrahydrofolate reductase (MTHFR); and transsulfuration to cysteine which requires cystathionine beta synthase (CBS) enzymes (Obeid and Herrmann 2006) . Severe hyperhomocysteinemia (HHcy), which results in abnormally high plasma homocysteine concentration, is usually caused by CBS deficiency (Selhub 1999; Watanabe et al. 1995) . HHcy is a common risk factor for stroke, vascular, and possibly neurodegenerative diseases (Beard and Bearden 2011; Kraus et al. 1999) .
HHcy causes increased oxidative stress by differential expressions of oxidant and anti-oxidant enzymes (Tyagi et al. 2005b) . Oxidative stress has been suggested to be involved in brain edema and post-ischemic neuronal damage (Abe et al. 1988) . Ischemia rapidly consumes endogenous antioxidants and produces excessive amounts of toxic free radicals (Chen et al. 2011) . The accumulation of these toxic free radicals plays an essential role in blood brain barrier (BBB) disruption through matrix metalloproteinases (MMPs) activation Romanic et al. 1998) . MMPs are membrane-bound, zinc-binding proteolytic enzymes that are essential for the breakdown of extracellular matrix (ECM) components of the basement membrane around cerebral blood vessels and neurons. MMPs are synthesized as pre-enzymes, secreted from cells as proenzymes, and activated by other proteases and free radicals in the extracellular compartment (Lee et al. 2005) . Among these MMPs, MMP-2 and MMP-9 are key enzymes (Romanic et al. 1998) . Several reports have suggested that MMP-9 plays a significant role in brain injury after cerebral ischemia Lee et al. 2004; Rosenberg et al. 1998) . Pharmacological inhibition of MMP-9 as well as targeted deletion of the MMP-9 gene in mice resulted in substantial reductions of brain damage after ischemia Wang et al. 2000) .
Jakubowski demonstrated that Hcy-induced vascular damage could be related to modification of proteins by a metabolite of Hcy, Hcy-thiolactone (N-homocysteinylation) (Jakubowski 2007; Jakubowski 2008) . Indeed N-homocysteinylation is elevated in CBS deficient patients and is more toxic than Hcy itself (Perla-Kajan et al. 2008) . N-homocysteinylation impairs protein function and leads to cell and tissue damage. In vitro studies have demonstrated homocysteinylation of cyto-c. Cyto-c is a mitochondrial peripheral membrane protein and is essential for mitochondrial function. Cyto-c is very susceptible to the modification by Nhomocysteinylation (Perla-Kajan et al. 2007; Zhao et al. 2010) . The role of N-Hcy-Cyto-c in autophagy during genetic HHcy is not clear.
Autophagy is a regulated process of degradation and recycling of cellular constituents (Rami et al. 2008) . Autophagy may help to promote cell survival (Rami et al. 2008) or may also promote cell death (Reggiori and Klionsky 2002) . There were evidences that autophagy increases in neurons in the periphery of the ischemia area after 6-24 h post injury (Rami et al. 2008) . In contrast, post-ischemic injections of the autophagy inhibitor 3-methyladenine (3-MA, an autophagy inhibitor) block the ischemia-induced increase in LC3-II and DRAM (autophagy marker). These results point out the need to develop autophagy inhibitors that could be more suitable than 3-MA for therapeutic purpose (Rami et al. 2008) .
Tetrahydrocurcumin (THC) is one of the major metabolites of curcumin with potent antioxidant and antiinflammatory activity (Pan et al. 1999) . Curcumin (diferuloyl methane) is a polyphenol compound, extracted from the rhizomes of the Curcuma longa plant (turmeric). Structurally, THC and curcumin are similar expect THC lacks the double bonds of curcumin (Okada et al. 2001) . However, recent attention has been focused on THC because it appears to exert a greater antioxidant activity in both in vitro and in vivo systems (Okada et al. 2001; Pari and Murugan 2004) . Unlike curcumin, THC is stable in all physiological buffers. In recent years, curcumin has been shown to be neuroprotective and also lower blood glucose levels in type 2 diabetes mice (Nishiyama et al. 2005) . However, the effect of THC on various aspects of HHcy has not been investigated. Thus, we explore in the present study the effect of THC on homocysteinylated cyto-c mediated autophagy in the well-characterized genetic model of severe HHcy in mice after cerebral ischemia.
Experimental Procedures

Mice
All experimental procedures were approved and carried out in accordance with the Institutional Animal Care and Use Committee of the University of Louisville. CBS heterozygous knockout mice (8-10-week-old) (CBS+/−) were obtained from Jackson Laboratory (Bar Harbor, ME) and maintained in the animal facility center at University of Louisville. The mice were fed with regular mice chow PMI ® LabDiet ® St Louis, MO (Cat # 5015) and water ad libitum. Mice genotypes were determined by a polymerase chain reaction of DNA obtained from tail biopsies with a specific set of primers (Kumar et al. 2008 ).
Focal Cerebral Ischemia
Animals weighing 22-25 g were anesthetized with sodium pentobarbital (70 mg/kg body wt.). Body temperature was controlled using a rectal temperature probe and maintained at 37±0.5°C by a thermostat-controlled heated blanket. Ischemia was induced by occlusion of the middle cerebral artery (MCAO), using a modified intraluminal technique. MCAO was performed with a silicone resin-coated 6-0 nylon monofilament (Ethicon, Titusville, N. J) which was introduced into a small incision of the left common carotid artery and advanced distal to the carotid bifurcation for temporary occlusion of the middle cerebral artery (30 min). Regional cerebral blood flow (CBF) was continuously monitored using a laser doppler probe (Moor Instruments, moor FLPI) to verify ischemia. The occlusion was established when the CBF dropped below 20% of the pre-MCAO flow-value. After 30 min of middle cerebral artery occlusion, blood flow was restored by withdrawal of the monofilament. Shamoperated mice were subjected to the same anesthesia and surgical procedure, except MCAO (Longa et al. 1989 ).
Administration of THC THC used in the study was purchased from Sabinsa Corporation, USA. (1) CBS+/− heterozygous knockout mice with vehicle treatment; (2) CBS+/− heterozygous knockout mice with THC treatment; (3) CBS+/− heterozygous knockout mice with ischemia/reperfusion injury (I/R); (4) CBS+/− heterozygous knockout mice with ischemia/reperfusion injury with THC treatment. THC was dissolved in 0.1% dimethyl sulfoxide (DMSO; Sigma, USA). Thirty minutes after MCAO, THC (25 mg/kg/day) or vehicle was given for 3 days by intra-peritoneal injection.
Assessment of Neurological Functional
After recovery from anesthesia and again after 72 h, neurological function was assessed according to the method of Longa et al. (1989) . Neurological findings were scored on a 5-point scale. No neurological deficit00, failure to extend right paw fully01, circling to right02, falling to right03, did not walk spontaneously and has depressed levels of consciousness04.
Determination of Infarct Volume
Animals were sacrificed 72 h after MCAO. Brains were quickly removed and frozen at −20°C for 10 min. Coronal sections were cut into 2 mm slice using a mouse brain slice matrix (Harvard Apparatus, Holliston, MA, USA). The slices were stained for 30 min at 37°C with 2% 2,3,5-triphenyltetrazolium chloride (TTC; SigmaAldrich, Taufkirchen, Germany) in PBS to visualize the infarctions (Bederson et al. 1986; Kleinschnitz et al. 2010 ).
Measurement of Brain Water Content
The water content of the brain tissue was measured by the wet and dry weight method as described previously (Fukui et al. 2003) . Briefly, brain tissue samples from CBS+/−+ vehicle, CBS+/−+THC, CBS+/−+I/R, and CBS+/− I/R+ THC mice were immediately weighed to obtain wet weight (WW). The tissue was then dried in an oven at 95°C for 72 h and weighed again to obtain the dry weight (DW). The formula (WW −DW)/WW × 100% was used to calculate the water content and expressed as a percentage of wet weight.
Evaluation of BBB Integrity
We investigated the integrity of the BBB in mice by measuring the extravasation of Evans blue (Belayev et al. 1996; Uyama et al. 1988) . Evans blue dye (2%, 4 mL/kg body weight) was slowly administered via carotid artery and allowed to circulate for 3 h in mice with or without THC treatment. At the end of the experiment, the mice were perfused with saline to wash away any remaining dye in the blood vessels. The dissected brain were weighed and extracted in 1.0 ml of 50% trichloroacetic acid solution. After homogenization and centrifugation, the extract was diluted with ethanol (1:3), and its fluorescence was determined at 620 nm (excitation) and 680 nm (emission) with a spectrophotometer (Spectra Max 3000, CA, USA).
In situ Zymography
In situ zymography gelatinolytic activity was assessed using a commercially available kit (Molecular Probes) as described previously (Gasche et al. 2001 ) with some modification. Thirty minutes of ischemia followed by 72 h of reperfusion, the animals were scarified, and the brains were frozen in 2-methylbutane with liquid nitrogen. Frozen brain were sectioned with a cryostat to a thickness of 30 μm and incubated for 3 h at 37°C with 400 μg/mL DQ gelatin conjugate (molecular probe), a fluorogenic substrate, after 3 h of incubation, sections were washed with PBS three times and fix in 4% paraformaldehyde. DQ gelatin cleaved by MMPs resulted in a green fluorescent product (excitation, 495 nm; emission, 515 nm).
Western Blot Analysis
Change in protein content during ischemia was assessed by Western blot analysis . Briefly, frozen brain tissue was washed twice with ice-cold PBS and lysed with ice-cold RIPA buffer (containing 5 mM of ethylenediaminetetraacetic acid), which was supplemented with phenylmethylsulfonyl fluoride (1 mM) and protease inhibitor cocktail (1 ml/ml of lysis buffer). Protein content of the lysate was determined using the bicinchoninic acid protein assay kit (BCA, Pierce,Rockford, IL). Equal amounts of protein (60 μg) were resolved on 10-15% SDS-PAGE and transferred onto a polyvinylidene difluoride membrane (PVDF, Bio-Rad) as described . The membranes were blocked with 5% non-fat dry milk in TBS-T (50 mM Tris-HCl, 150 mM NaCl, 0.1% Tween-20, pH 7.4) and incubated with respective primary antibodies for 3 h at room temperature. After probing with appropriate secondary antibodies for 1.5 h at room temperature, the blots were analyzed with Gel-Pro Analyzer software (Media Cybernetics, Silver Spring, MD) as described earlier . Membranes were stripped and re-probed for GAPDH as a loading control. The protein expression intensity was assessed by integrated optical density (IOD) of the area of the band in the lane profile.
To account for possible differences in the protein load, measurements presented are the IOD of each band under study (protein of interest) divided by the IOD of the respective GAPDH band.
Confocal Microscopy
Hcy level in brain tissue during ischemia was assessed by immunohistochemistry analysis as described earlier . Samples of brain tissue from all experimental groups were immediately placed onto freezing media and were stored at −70°C until they were used. Briefly, sections were post-fixed in 4% of paraformaldehyde and labeled with Hcy antibody (Abcam Antibodies, Cambridge, MA). After an overnight incubation, sections were washed with PBS and incubated with appropriate secondary antibody conjugated with Texas Red. After washing, sections were mounted with FluoroGel mounting medium (GeneTex, Inc) and visualized with confocal microscopy (Olympus, FluoView 1000, objective 60×). DAPI was used for nuclei staining. Total fluorescence (red) intensity in five random fields (for each experiment) was measured with image analysis software (Image-Pro Plus, Media Cybernetics) and expressed in fluorescence intensity units (FIU). The fluorescence intensity values were averaged for each experimental group.
Reverse Transcription-Polymerase Chain Reaction
The RT-PCR was performed for mRNA expression of SAHH, MTHFR, and GAPDH in all experimental group using ImProm-II™ Reverse Transcription system kit (Promega Corporation, Madison, WI, USA, cat # A3800) as described elsewhere (Mishra et al. 2010 ). For gene amplification the RT-PCR program was 95°C-7.00 min [95°C-0.50 min, 55°C-1.00 min, 72°C-1.00 min] ×34, 72°C-5.00 min, 4°C−∞. The primers for RT-PCR are: MTHFRforward 5′-CTACCAGAGCCCAAGACAGC-3′; reverse 5′-ATTGCAGTTGCTCCTTGTCC SAHH-forward 5′-CGATTCTGTCACCAAGAGCA-3′; reverse 5′-TGAAG GAGTTGCTCATCACG-3′ ; GAPDH forward 5′ -TGTTGCTGTAGCCGTATTCA-3′; reverse 5′-CAACAG CAACTCCCACTCTT-3′. The RT-PCR product was electrophoresed on 1% agarose gel in TAE with 0.008% ethidium bromide. All of the data were analyzed using GAPDH as loading control.
Quantitative Real-Time PCR Quantitative real-time PCR (QRT-PCR) for SAHH and MTHFR genes was performed using an Mx3000p QPCR method as described previously ). The first-strand cDNA reaction (0.5 μl) was subjected to realtime PCR amplification using gene-specific primers. The sequences of the primers used are as follows: SAHH: 5′-ACTGAGAAGCAGGCCCAGTA-3′ (forward) and 5′-CACTGTCCAGGCTACTGCAA-3′ (reverse) and MTHFR: 5′-CCATCCTCAGACCCTGTTGT-3′ (forward) and 5′-CGTCCACGATGTGGTAGTTG-3′ (reverse); GAPDH 5′-CAACAGCAACTCCCACTCTT-3′ (forward) and 5′-TGTTGCTGTAGCCGTATTCA-3′ (reverse). Real-time PCR assays were performed in ∼25-μl reactions, consisting of 2× (12.5 μl) Brilliant SYBR Green QPCR Master Mix (Stratagene), 400 nmol/L primers (0.5 μl each from the stock), 11 μl of water, and 0.5 μl of template. The thermal conditions consisted of an initial denaturation at 95°C for 10 min followed by 40 cycles of denaturation at 95°C for 15 s, annealing, and extension at 56°C for 1 min, and, for a final step, a melting curve of 95°C for 15 s, 56°C for 15 s, and 95°C for 15 s. All reactions were performed in triplicate to reduce variation. Data normalization was accomplished using GAPDH as an endogenous control, and the normalized values were subjected to a 2 −ΔΔCt formula to calculate the fold change between the control and experimental groups.
Co-immunoprecipitation
Protein-A Sepharose beads were pre-incubated at 4°C for 3 h-overnight with rabbit anti-cyto-c antibody (Abcam) or rabbit isotype control IgG at the dilution of 1:100 with 0.1% BSA in TBST. Then 250μl of protein homogenates were incubated at 4°C overnight with 50μl of the protein-A Sepharose beads. Thereafter, the mixtures were centrifuged and the supernatants were collected. The supernatants were incubated with anti-cyto-c antibody coated beads or isotype control IgG-coated beads at 4°C for 3 h. The beads were then picked up, and proteins were resolved in laemmli sample buffer. The extracts were used for Western blotting to detect the protein that interacts with cyto-c. For detection of cyto-c through western blotting, conformational specific anti-rabbit IgG (Abcam) was used to avoid cross-reaction of a secondary antibody with rabbit IgG light chain. 
Results
Effect of THC on Cerebral Infarction and Neuroscore
To determine the neuroprotective effect of THC against ischemia/reperfusion insult, we measured the infarct volume and neuroscore with or without THC administration. The infarct volume and neuroscore were significantly increased in CBS+/− ischemic group as compared to sham-operated group (CBS+/−) (Fig. 1a, b) . While the infarct volume and neuroscore were significantly decreased in THC-treated mice as compared to CBS+/-ischemic mice (Fig. 1a, b) . As shown in Fig. 1a , a remarkably decreased pale-colored region was observed in the THC-treated mice brain as compared with CBS+/-ischemia/reperfusion. These observations indicate that THC can prevent the ischemia/reperfusioninduced brain injury.
Effect of THC on Blood Brain Barrier Integrity after Focal Cerebral Ischemia
Increased vascular permeability and disruption of the blood brain barrier (BBB) could be initiating factors for the development of cerebral injury and critical factors for the determination of post-ischemic severity. To elicit the effect of THC administration on BBB permeability, we quantified the extravasation of Evans blue in the brain as an indicator of BBB breakdown. In the sham-operated group (CBS+/−), the content of Evans blue was unchanged (Fig. 2a) . The levels of Evans blue were significantly increased in CBS+/− ischemic group as compared to sham-operated group (CBS+/−) (Fig. 2a) . While the extravasation of Evans blue were significantly decreased in THC treated mice as compared to CBS+/− ischemic mice (Fig. 2a) . Increased vascular permeability results in edema formation, which is a major complication in strokes. Brain water content, as the index of cerebral edema, was higher in the CBS+/− ischemic group as compared to sham-operated group (CBS+/−). Administration of THC produced a significant decrease in post-ischemic cerebral edema (Fig. 2b ) as compared to CBS+/− ischemic group. These results indicate that THC could improve post-ischemic brain injury by decreasing the vascular permeability and edema.
Effect of THC on Homocysteine Metabolism
Stress decreases MTHFR and increases SAHH echelons thus causing an increase in total Hcy levels in tissue. We measured mRNA expression of Hcy metabolic enzymes MTHFR and SAHH. Induction of ischemia significantly decreases the expression of MTHFR whereas SAHH expression was increased in CBS+/− ischemic group as compared to sham-operated group (CBS+/−) ( Fig. 3a-d) . Supplementation with THC restored expression of SAHH and MTHFR in ischemic brain ( Fig. 3a-d) . Impairment in Hcy metabolism causes an increased in total Hcy levels. To assess the effect of THC on total Hcy levels during cerebral ischemia, we evaluated total Hcy levels in brain tissue by immunohistochemistry in all the groups. Total Hcy levels were robustly increased in ischemia groups as compared to sham operator groups (Fig. 3e, f) . The THC treatment significantly reduced total Hcy level in CBS+/− I/R+THC group as compared to CBS+/− I/R groups. These results suggest the inhibitory action of THC on Hcy levels (Fig. 3) .
Effect of THC on Oxidative Stress
To test whether elevated levels of homocysteine-caused oxidative stress during ischemia/reperfusion injury, we measured protein expression of p47phox (oxidant enzyme) and catalase (antioxidant enzyme). Protein level of p47phox was significantly up-regulated in CBS+/− ischemic group as compared to the sham operator groups (CBS+/−) whereas protein level of catalase was significantly down-regulated in CBS+/− ischemic group as compared to sham operator groups (Fig. 4a, b) . Treatment with THC mitigates these effects. These results suggested that during brain injury, increased total Hcy level caused elevation in oxidative stress and THC treatment attenuated these effects (Fig. 4) .
Effect of THC on Homocysteinylation of Cytochrome-c
To determine whether an increase in Hcy levels cause protein N-homocysteinylation of cyto-c during ischemia/reperfusion injury and induce autophagy. In the ischemic brain, the levels of cyto-c homocysteinylation were increases as compared to sham-operated group. THC treatment inhibits the homocysteinylation of cyto-c (Fig. 4c) . N-linked Hcy thiol group was blocked by the treatment with THC (Fig. 4) .
Effect of THC on MMPs
MMP-9 is a known marker for cerebral injury. To assess total MMPs activity, in situ DQ-gelatin zymography was performed in fresh brain slices from all groups. There was a marked increase in gelatinolytic activity in the ischemic group as compared to sham operator groups (CBS+/−) ( Fig.5a-d) . Gelatinolytic activity was reduced in the THCtreated groups (Fig. 5a-d) . To verify the gelatinolytic activity result, we performed Western blot in all groups (Fig. 5e, f) Interestingly, MMP-9 protein expression was markedly increased in CBS+/− ischemia groups as compared to sham operator groups (CBS+/−) (Fig. 5e, f) . These results suggested that THC administration significantly inhibited the induction of MMP-9 (Fig. 5) .
Anti-autophagy Effect of THC Ischemia/reperfusion injury induces autophagy. Our results showed LC3-II levels and DRAM protein expression was increased in CBS+/− ischemic group as compared to sham operator groups (Fig. 6) . Administration of THC inhibited the conversion of LC3-I to LC3II (Fig. 6a, c) and also decreased the protein expression of DRAM in CBS+/− ischemic group as compared to sham operator groups (Fig. 6b, d ). These results suggested that protective effects of THC are associated with the anti-autophagic effect after cerebral ischemia/reperfusion injury, in part, by homocysteinylation of cyto-c and activation MMP-9.
Discussion
The aim of this study was to investigate the neuroprotective effects of tetrahydrocurcumin, a polyphenolic nonenzymatic antioxidant agent, against Hcy-induced neurotoxicity. The goal was to establish an animal model of genetically hyperhomocystemia. Previously, Jiang et al. (2007) showed the neuroprotective effect of curcumin during cerebral ischemia/reperfusion injury in rat (Thiyagarajan and Sharma 2004) .
Results of the present study shows that THC decreased infarct volume and improved neurological outcomes after ischemic/reperfusion injury (I/R) (Fig. 1) in genetically hyperhomocystemia mice. Tetrahydrocurcumin diminishes homocysteinylation of cyto-c by decreasing oxidative stress, MMP-9 and provides neuronal protection through autophagy mechanisms. Disruption of the blood-brain barrier occurs under various pathological conditions such as I/R injury. Which causing to an increased vascular permeability with subsequent development of brain edema (Utepbergenov et al. 1998) . Protection of the blood-brain barrier has become an important experimental therapeutically target during I/R injury (Veltkamp et . In the present study, our results indicate that THC inhibited the neurotoxicity of Hcy by decreasing water content of the brain and prevented the absorbance of Evans blue dye after I/R injury, suggesting that THC protects blood-brain barrier integrity by reducing endothelial cells damage (Fig. 2) (Jiang et al. 2007 ).
In the body, Hcy is formed from methionine and can be metabolized to cystathionine or methylated to methionine by three enzymes MTHFR, SAHH, and CBS. CBS enzyme is the first enzyme of the transsulfuration pathway (Kleinschnitz et al. 2010) and directly involved in the removal of Hcy from the methionine cycle (Finkelstein 1998) . Deficiency of CBS enzyme caused homocystinuria (Kleinschnitz et al. 2010) . In order to understand the role of THC treatment in expression of Hcy metabolic pathway genes in brain tissue, we measured the mRNA expression of MTHFR and SAHH. QRT-PCR results revealed downregulation of MTHFR and up-regulation of SAHH genes in CBS+/−+I/R group which was mitigated with THC supplementation ( Fig. 3a-d) . These results suggest that THC retain transsulfuration and remethylation pathways, thus reduce the total Hcy level (Fig. 3e, f) .
It is well known that Hcy causes cell detachment and cell death by creating oxidative stress (Tyagi et al. 2005b; Tyagi et al. 2006) . Thus, the generation of excessive free radicals (ROS) during I/R injury in genetic HHcy condition plays a major role in brain injury associated with stroke. Our result showed that tetrahydrocurcumin treatment significantly decreased oxidative stress by down-regulating oxidant enzyme (phox47) and up-regulating anti-oxidant enzyme (catalase) expression after I/R injury. Our results are consistent with earlier observations regarding the antioxidant role of THC (Fig. 4) .
It is known that Hcy induces cerebral arteriolar stiffness and finally brain dysfunction (Nappo et al. 1999) . The mechanism involves (1) Hcy toxicity is the modification of proteins by a Hcy metabolite, i.e., Hcy-thiolactone (HTL); (2) protein modification by HTL is N-homocysteinylation. The N-homocysteinylation has detrimental effects on protein structure and function (Jakubowski 2006 ) causing vascular diseases. In this study, we examined the effect of HHcy on homocysteinylation of cyto-c during I/R injury (Fig. 5 ). Our findings demonstrate that THC restrain homocysteinylation of cyto-c by decreasing oxidative stress, which in turn initiate MMP-9 activation.
Increasing evidence has indicated that MMP-2 and MMP-9 level increases in brain injury (Mun-Bryce and Rosenberg 1998; Strickland et al. 1996; Wang and Tsirka 2005; Zhao et al. 2007 ). In HHcy conditions, early appearance of MMP-2, MMP-9 has been reported in cardiovascular diseases and neurovascular diseases Sen et al. 2007 ). MMPs, especially MMP-9, have a critical function in proteolytic degradation of the BBB in the pathological process. The lack of MMP-9 gene showed less edema than their WT littermates in a model of ICH Xue et al. 2006) , as well as in cerebral ischemia (Asahi et al. 2001) . In this study, we showed that increased gelatinolytic activity as well as protein expression in CBS+/− ischemic mice was significantly reduced by THC treatment. The results suggest that MMPs are also implicated in I/R injury induced brain dysfunction, at least in part, through MMP-9 activation. These data collectively support the neuro-protective effect of THC (Fig. 6) . Previous studies have demonstrated that THC downregulates the MMP-2 and MMP-9 expression (Yodkeeree et al. 2008; Yodkeeree et al. 2009 ) during cancer cell invasion. Cellular organelles are the prime target for Hcy toxicity. However, the effect of HHcy on autophagy particularly in ischemic condition and its consequence on brain function has not ever been questioned. However, the role of autophagy under HHcy conditions was controversial. It has been reported that Hcy induced apoptosis (Tyagi et al. 2005a; Tyagi et al. 2006) or autophagy/mitophagy (Dennis and Mercer 2009 ). Uchiyama's group reported that in a mouse ischemia-hypoxia model, many damaged neurons showed some features of autophagic/lysosomal cell death (Adhami et al. 2006; Adhami et al. 2007; Ventruti and Cuervo 2007) . In contrast, one study showed that autophagy is associated with neuroprotection (Ventruti and Cuervo 2007). Thus, the role of autophagy in cell death and survival in cerebral ischemia remains to be defined. In this study, we have demonstrated that THC ameliorates autophagy in genetically HHcy mice after cerebral ischemia/reperfusion injury. Our results indicated that autophagy occurred with increase in the protein level of DRAM and degradation of LC3-I to LC3-II (Fig. 6) . Autophagy may represent a novel mechanism by which permanent ischemic stroke induces neuronal death, and inhibition of the activation and maturation of autophagy may help reduce ischemic injury. In conclusion, if hyperhomocysteinemia is one of the pathological reasons for neurodegenerative disorders (stroke), THC may be an effective prophylactic agent in the prevention of oxidative stress by Hcy. Furthermore, data of this study suggest that antioxidant property of THC may be responsible for protection against Hcy oxidative stress, possibly by increasing the endogenous defenses against oxidative stress and hence improves brain functions. Further studies are required to reveal the exact mechanism of Hcy in cell death process (apoptosis or autophagy) and the neuroprotective properties of THC must be studied in more detail. Rationale Cystathionine-beta synthase deficient homozygous mice suffer from severe growth retardation and a majority of them are dead by 5 weeks of age. Histological examination showed that the hepatocytes of homozygotes were enlarged, multinucleated, and filled with microvesicular lipid droplets. Plasma homocysteine levels of the homozygotes were approximately 40 times normal. Heterozygous mutants have an approximately 50% reduction in cystathionine betasynthase mRNA and enzyme activity and have twice normal plasma homocysteine levels. Thus, the heterozygous mutants are promising for studying the in vivo role of elevated levels of homocysteine.
